ABLYNX TO PRESENT AT THE ANNUAL JEFFERIES 2013 GLOBAL HEALTHCARE CONFERENCE
(Thomson Reuters ONE) -
GHENT, Belgium, 29 May 2013 - Ablynx [Euronext Brussels: ABLX] today announces
it will present at the annual Jefferies 2013 Global Healthcare Conference in New
York on Monday,
3(rd) June 2013 at 01:30 p.m. EST (07:30 p.m. CET).
The presentation, followed by a Q&A, will be hosted by Dr Edwin Moses, CEO and
Chairman of Ablynx. The presentation will provide an update on the Company's
late-stage proprietary Nanobody® programmes, the Company's growth and partnering
strategy and the outlook for the near term future.
The presentation will be webcast live and can be accessed on the day via the
Ablynx website at www.ablynx.com. A replay of the webcast will be available on
the Company's website for 30 days following the presentation. To ensure a timely
connection, it is recommended that users register at least 10 minutes prior to
the scheduled webcast.
About Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development
of Nanobodies(®), a novel class of therapeutic proteins based on single-domain
antibody fragments, for a range of serious human diseases, including
inflammation, haematology, oncology and pulmonary disease. Today, the Company
has approximately 25 programmes in the pipeline and five Nanobodies at clinical
development stage. Ablynx has on-going research collaborations and significant
partnerships with major pharmaceutical companies including Boehringer Ingelheim,
Merck Serono, Novartis and Merck & Co. The Company is headquartered in Ghent,
Belgium.
More information can be found on www.ablynx.com.
For more information, please contact
Ablynx:
Dr Edwin Moses
Chairman and CEO
t: +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
+32 (0)473 39 50 68
e: edwin.moses(at)ablynx.com
Marieke Vermeersch
Associate Director Investor Relations
t: +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e: marieke.vermeersch(at)ablynx.com
Follow us on Twitter (at)AblynxABLX
M:Communications:
Mary-Jane Elliott, Amber Bielecka, Claire Dickinson
t: +44 207 920 2330
e: ablynx(at)mcomgroup.com
press release in pdf format:
http://hugin.info/137912/R/1705608/564256.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ablynx via Thomson Reuters ONE
[HUG#1705608]
Unternehmensinformation / Kurzprofil:
Datum: 29.05.2013 - 18:00 Uhr
Sprache: Deutsch
News-ID 264549
Anzahl Zeichen: 3030
contact information:
Town:
Ghent/Zwijnaarde
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 221 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ABLYNX TO PRESENT AT THE ANNUAL JEFFERIES 2013 GLOBAL HEALTHCARE CONFERENCE"
steht unter der journalistisch-redaktionellen Verantwortung von
Ablynx (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
